About
Tenomix Inc. is a Canadian MedTech startup based in London, Ontario, focused on enhancing cancer tissue processing within the pathology workflow. Founded in July 2021 by a team of experts, the company aims to improve cancer diagnostics by addressing inefficiencies in pathology, particularly in lymph node dissection for colon cancer tissues. The company's flagship product is an automated benchtop device that combines robotics, ultrasound imaging, and artificial intelligence to streamline lymph node identification. This innovation significantly reduces the manual labor and error rates associated with traditional methods, enhancing the accuracy and consistency of cancer staging. Tenomix collaborates with clinicians, pathologists, and research institutions to ensure its technology meets clinical needs and regulatory standards. Tenomix's solutions support pathology laboratories, cancer care centers, hospitals, and research institutions in improving diagnostic accuracy and patient outcomes. The company has received substantial funding, including a $10-million investment from the Government of Canada, to accelerate the adoption of its technology in clinical settings.
Technologies
Keywords
Company Information
-
Employees 13
-
Founded 2021
Location
London, Ontario, Canada
